PLEXAPR Trademark

Trademark Overview

On Friday, June 26, 2020, a trademark application was filed for PLEXAPR with the United States Patent and Trademark Office. The USPTO has given the PLEXAPR trademark a serial number of 90022305. The federal status of this trademark filing is REGISTERED as of Tuesday, January 4, 2022. This trademark is owned by PLEXISION, INC. The PLEXAPR trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical bloods testing for diagnostic purposes in to measure Antigen Presentation of Mono Nuclear Cells
plexapr

General Information

Serial Number90022305
Word MarkPLEXAPR
Filing DateFriday, June 26, 2020
Status700 - REGISTERED
Status DateTuesday, January 4, 2022
Registration Number6609304
Registration DateTuesday, January 4, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2020

Trademark Statements

Goods and ServicesMedical bloods testing for diagnostic purposes in to measure Antigen Presentation of Mono Nuclear Cells
Pseudo MarkPLEX APR-M

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 23, 2020
Primary Code044
First Use Anywhere DateSaturday, September 19, 2020
First Use In Commerce DateMonday, June 14, 2021

Trademark Owner History

Party NamePLEXISION, INC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15224
Party NamePLEXISION, INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15224
Party NamePLEXISION, INC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPittsburgh, PA 15224

Trademark Events

Event DateEvent Description
Tuesday, January 4, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, December 2, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, December 1, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 12, 2021DATA MODIFICATION COMPLETED
Monday, November 8, 2021ASSIGNED TO LIE
Friday, November 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 4, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 14, 2021USE AMENDMENT FILED
Thursday, November 4, 2021EXTENSION 1 GRANTED
Monday, July 19, 2021EXTENSION 1 FILED
Thursday, November 4, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 15, 2021NOTICE OF REVIVAL - E-MAILED
Thursday, October 14, 2021EXTENSION RECEIVED WITH TEAS PETITION
Thursday, October 14, 2021PETITION TO REVIVE-GRANTED
Thursday, October 14, 2021TEAS PETITION TO REVIVE RECEIVED
Thursday, October 14, 2021TEAS STATEMENT OF USE RECEIVED
Monday, August 23, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 23, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 21, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, October 21, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 21, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, October 21, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, October 2, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 2, 2020NON-FINAL ACTION E-MAILED
Friday, October 2, 2020NON-FINAL ACTION WRITTEN
Tuesday, September 29, 2020ASSIGNED TO EXAMINER
Thursday, July 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

plexapr presentation mono nuclear cells antigen measure bloods testing diagnostic purposes